Matches 1 - 50 out of 72 1 2 >


Match Document Document Title
DE102018007483A1 Medicinal or nutritional supplement or cosmetic health care product for the treatment and / or prophylaxis of skin and connective tissue diseases, especially neurodermatitis by activating the dermal cell metabolism  
Medicinal or nutritional supplements for the treatment and / or prophylaxis of skin and / or connective tissue diseases, with a collagen hydrolyzate in combination with tannins from plant...
DE102018007482A1 Medicinal or nutritional supplements for the treatment of COPD and / or for increasing the oxygen saturation (VO2max) and / or for reducing the serum lactate production  
Medicinal or nutritional supplements for the treatment of COPD and / or for increasing the physical endurance and / or for increasing the oxygen saturation (VO2max) and / or for reducing the serum...
DE102018007480A1 Medicinal or nutritional supplements for maintaining the health of brain cells and / or treating damaged brain cells by activating the cell metabolism of the brain cells and / or for preventive protection by increasing the concentration of antioxidants in the brain.  
Medicinal or nutritional supplements for maintaining the health of brain cells and / or treating damaged brain cells by activating the cell metabolism of the brain cells and / or for preventive...
DE102018007477A1 Medicinal or nutritional supplement or cosmetic health care product for the treatment and / or prophylaxis of skin and connective tissue diseases by activating the dermal cell metabolism and / or for the preventive protection of the skin cells  
Medicinal or cosmetic health care agent for the treatment and / or prophylaxis of diseases of the skin and connective tissue and / or the preventive protection of skin cells which contain a...
DE202019001624U1 Adhesive gel for the discharge of EEG, EP and NLG, water-soluble, conductive and adhesive  
The claim for protection relates to: The composition of the ingredients of the recipe - gum arabic, povidone, dextrose, 1,2-propanediol and sodium chloride.
DE102017010898A1 New inhibitors of shikimic acid pathway  
The present invention relates to novel inhibitors of the shikimic acid pathway (shikimate route), to pharmaceutical compositions containing these novel inhibitors, to processes for the preparation...
DE102017007658A1 Veterinary composition and its use  
The problem with the available galenical compositions in the veterinary field is that they do not adequately transport active substances into inflammatory diseases and postoperative therapies into...
DE202017005548U1 Mannose derivatives in food to prevent, control and improve urinary tract infections and cystitis  
Foodstuff, characterized in that it contains the sugar mannose, of synthetic or natural origin.
DE202018002817U1 Tablet of calcium caseinate and xylitol to promote remineralization of the teeth  
Preparation of a suitable, dispensable tablet for the purpose of promoting the saliva in the remineralisation of the tooth surface by applying a toothpain containing calcium and xylitol,...
DE202018000323U1 Solution and suspension basis  
A basis for the preparation of pediatric solutions and suspensions for oral administration by the addition of one or more active pharmaceutical ingredients, characterized by a composition...
DE102016002654A1 Use of a gelatin matrix to ensure the functionality or to improve the quality of the use of one or more medicinal or food supplements for the treatment and / or prophylaxis of mobility problems, bone disorders, weakness of the connective tissue, immune system weakness, regeneration after exercise and / or disease by including the active ingredients in the same.  
(S) for the treatment and / or prophylaxis of - but not limited to - mobility problems, bone diseases, connective tissue weakness, immune system weakness, regeneration after sporting Operation and...
DE102016002090A1 Composition for the dietary supplement human nutrition and their use  
A problem with compositions from the dietary supplements sector that this used to treat muscle defects and -rissen should regularly highly complex compositions, which have unpredictable side...
DE102011105594B4 Substance mixture and infusion or drinking solution  
A mixture of substances, which is a liquid mixture containing ribose, alanine, glycine and glutamine in an aqueous solution, the aqueous solution containing between 60 g / l and 120 g / l ribose,...
DE102016100330A1 New type of medical radiation protection spray  
The present invention relates to a new type of medical radiation protection spray which can prevent and reduce the injury to skin and mucosa caused by radiation, and can also accelerate the...
DE102012007165B4 Acid dialysis concentrate  
Precursor of an acidic dialysis concentrate, wherein from the ingredients of the acidic dialysis concentrate two separately provided partial concentrates are formed, whereby only one partial...
DE19861497B3 Babies' food and their use for the promotion of human colorectal flora  
According to the invention, baby food containing at least two different, soluble carbohydrates is provided. This baby food is characterized by the fact that the carbohydrates consist of a...
DE19861508A1 Carbohydrate mixture  
According to the invention, a carbohydrate mixture is provided for dietary diets and pharmaceuticals containing at least two different, soluble carbohydrates. This carbohydrate mixture is...
DE102015009946A1 Life Energy Reseter Development of an active substance (drug) for immunization in colds  
Main claim Cure for immunization and prevention in colds With long-term therapeutic treatment Under pressure: allows an intensive in and expiration through mouth and nose With all possible...
DE102014013885A1 dialysis solution  
The present invention relates to a dialysis solution containing bicarbonate, calcium and phosphate, where the phosphate dialysis solution having a concentration in the range of up to 0.4 mmol / l,...
DE102014104676A1 Fosfomycin preparation, a method for producing the preparation, and a preparation containing the polymethyl methacrylate bone cement powder  
There is described a fosfomycin preparation which contains a) a calcium salt of fosfomycin and b) greater comprises at least one sugar alcohol with a melting point of 70 ° C, wherein the weight...
DE202013006354U1 Composition of matter for the treatment of coagulopathies  
Composition of matter comprising ribose, and the amino acids alanine and glycine for use as a medicament or food supplement for the treatment of sepsis and / or coagulopathies, in particular...
DE102012104451A1 Composition for treating a disorder of circadian rhythm  
Composition comprising NADH and D-galactose for treating a disorder of circadian rhythm, in particular further comprising vitamins and / or coenzymes and / or minerals.
DE102012007165A1 Acid dialysis concentrate  
The precursor of an acid dialysis concentrate is characterized in that the constituents of the acid dialysis concentrate are used to form two separately provided partial concentrates, only one...
DE102012001146A1 Use of mannitol-/glucose mixture for producing drugs having diuretic effect during administration, preferably intravenous administration of iodinated X-ray contrast agent  
Use of mannitol-/glucose mixture for producing drugs having diuretic effect during administration, preferably intravenous administration of iodinated X-ray contrast agent, is claimed. ACTIVITY :...
DE202012012289U1 Dialysier and substitution fluid  
Dialysis and Substitionsflüssigkeit or solution, intended for elimination methods with citrate anticoagulation in intensive care area, characterized in that the solution 125 and 135 mmol / l Na, 0...
DE102011105594A1 Mixture useful as a medicament and/or for producing a medicament, preferably infusion- or drinking solution, comprises ribose, alanine and glycine  
Mixture comprises ribose, alanine and glycine. An independent claim is also included for an infusion- or a drinking solution comprising the ingredients of the liquid mixture in 10-100times,...
DE102010053567A1 Formulation and device, useful for local increase of efficiency and practical use of preventive or mitigation measure against hypoglycemia, comprise a sprayable formulation comprising a mixture of a sugar and a sodium ion releasing salt  
Formulation and device comprise a sprayable formulation comprising a mixture of a sugar and a sodium ion releasing salt, where the sugar D-glucose and the sodium-ion releasing salt are sodium...
DE202011002370U1 Mixture and Infusion drinking solution  
Substance mixture, characterized in that the substance mixture ribose, alanine and glycine.
DE102010045185A1 Mixture, use and infusion solution  
The present invention provides a composition, wherein the composition of matter ribose, alanine, nicotinic acid and ascorbic acid.
DE202011002371U1 Mixture, use and infusion solution  
Substance mixture, characterized in that the substance mixture ribose, alanine, nicotinic acid and ascorbic acid.
DE202011004859U1 Medicinal or dietary supplement for the treatment and / or accelerating the recovery from disease and / or after power peaks  
Medication or dietary supplement for the treatment and / or accelerating the recovery from disease and / or power spikes that a combination of ingredients with high bioavailability and...
DE202011004857U1 Medicinal or dietary supplement for the treatment and / or prophylaxis of bone disease  
Medicinal or dietary supplement for the treatment and / or prophylaxis of bone disorders, comprising a hydrolyzate, characterized by free hydroxyproline.
DE202011004861U1 Medication or dietary supplement for the treatment and / or prophylaxis of skin and connective tissue diseases  
Medicinal or dietary supplement for the treatment and / or prophylaxis of bone disorders, comprising a hydrolyzate, characterized by free hydroxyproline.
DE202009018155U1 In order to prevent urinary tract infections to control composition of a cranberry derivative and D-mannose, and to improve  
A human dietary supplement composition for use in preventing, controlling, ameliorating the evoked of E. coli urinary tract infections, by administering a therapeutically effective amount of a...
DE112009000125T5 In order to prevent urinary tract infections to control use of a composition of a cranberry derivative and D-mannose, and to improve  
Use of a human dietary supplement composition for preventing, controlling, ameliorating the evoked of E. coli urinary tract infections, by administering a therapeutically effective amount of a...
DE212008000064U1 Device for monitoring the Diabetes Insulin therapy  
Device for monitoring of diabetes-insulin therapy (versions), which is based on optical and / or electrochemical measurements of the properties of the environment under examination, preferably the...
DE102008061247A1 Inhibitors of dimethylarginine dimethylaminohydrolase  
Inhibitor of dimethylarginine dimethylaminohydrolase (DDAH) of the general structural formula, in whichB is a branched and unbranched, substituted or unsubstituted, saturated or unsaturated...
DE102008020797A1 Skin cream useful for e.g. treatment and/or prophylaxis of dry skin and/or skin damage in diabetic foot, comprises saccharide e.g. mannobiose, polysaccharide e.g. dextran, multivalent alcohol e.g. glycerol, urea, polycation and carrier  
Skin cream comprises at least one saccharide, at least one polysaccharide, at least one multivalent alcohol, urea, at least one polycation and at least one pharmaceutically or cosmetically...
DE202008003509U1 A pharmaceutical composition for prophylaxis and treatment of atherosclerosis, as well as for pain and inflammation  
Liquid, aqueous formulation comprising: (A) one or more polyols selected from the group consisting of: aldoses, ketoses, reduced aldoses and / or ketoses, physiologically acceptable glycosides of...
DE102008017590A1 Glucopyranosidderivate  
New compounds of formula I whereinX has the meaning given in claim 1, useful as antidiabetic agents.
DE102009011742A1 Aqueous liquid formulation, useful for treating migraine, comprises phospholipids, coenzyme Q10, blueberry extract (extract of Vaccinium myrtillus), and polyol comprising e.g. aldose, ketose, reduced aldose and/or ketose  
Aqueous liquid formulation (I) comprises: one or more phospholipids (a) (0.1-30 wt.%); coenzyme Q10 and/or its derivatives (b) (0.05-20 wt.%); blueberry extract (extract of Vaccinium myrtillus)...
DE102007026713A1 New 5-keto-D-fructose useful as medicaments, foodstuff e.g. marmalade, pasta, chocolate or sauces, sweetener, and for preparing products that are useful in the therapy of adiposity or diabetes  
5-Keto-D-fructose (I) useful in the medicines, is new. ACTIVITY : Antidiabetic. MECHANISM OF ACTION : None given.
DE102007016283A1 Deoxy-D-glucose for producing drug for therapy of arteriosclerosis and arteriothrombosis, particularly for plaque structure in vessel, for preventing or treating restenosis, and for use with compound for continuous release  
The 2-deoxy-D-glucose. ACTIVITY : Antiarteriosclerotic; Anticoagulant; Thrombolytic; Vasotropic. MECHANISM OF ACTION : None given.
DE112005001269T5 Polysaccharidextrakt from Lycium barbarum as a neuroprotective agent against ß-amyloid peptide toxicity Euro  
water-soluble Extract containing polysaccharide comprising arabinose, galactose, Glucose, xylose, rhamnose, mannose, glucuronic acid and galacturonic acid analyzed, by gas chromatography, which...
DE102006053690A1 New anionic cyclopentadienyl-carbohydrate compounds useful in the preparation of metallocene-carbohydrate compound, which is useful to treat cancer  
Anionic cyclopentadienyl-carbohydrate compounds (I), are new. Anionic cyclopentadienyl-carbohydrate compounds of formula (I), are new. m : 0-10 (preferably 1); ER1 : OH, alkoxy, nucleo-base or...
DE102006014543A1 Functional foods against tumors  
The present inventions furthermore relates to the technical field of functional Foodstuffs, either novel functional foods for the treatment and / or Prevention of malignant Tumor diseases of the...
DE10392416B4 Blood Breastfeeding Association  
Blood Breastfeeding Association containing a hemostatic layer of a textile carrier is with hemostatic drugs, wherein the textile support active or nonwoven fabrics having a sorption capacity with...
DE102004023828A1 Peritoneal dialysis solution  
The This invention relates to a solution for peritoneal dialysis, comprising from one or more individual solutions. A side-effect free treatment with simultaneous lowering of blood pressure let...
DE19829844B4 Use of D-galactose to prevent necrosis  
use of D-galactose and / or one or more D-galactose derivative / s - except hepatotoxic acting derivatives with galactosamine - prevention or reduction of necrosis or cell tissue damage.
DE102004012676A1 New glucopyranosyl-substituted benzene derivatives are sodium-dependent glucose cotransporter inhibitors, useful for treating e.g. metabolic disorders (type 1 and type 2 diabetes mellitus or metabolic acidosis)  
Glucopyranosyl-substituted benzene derivatives (I) and their tautomers, sterioisomers andsalts are new. Glucopyranosyl-substituted benzene derivatives of formula (I) and their tautomers,...

Matches 1 - 50 out of 72 1 2 >